• Publications
  • Spotlight on pharmaceutical companies’ action...
Published on 25 May 2022

Spotlight on pharmaceutical companies’ actions in women’s health and SRHR

Ahead of a special report in the 2022 Access to Medicine Index, the Foundation has published a Briefing on key issues in women's health and SRHR (sexual and reproductive health and rights), and the role of pharmaceutical companies in making sure essential health products are available and accessible to women in low- and middle-income countries (LMICs).

Explore further

Get in touch

Back to top |